Tandem Diabetes prices $120M IPO

Tandem Diabetes Care prices its 8-million-share initial public offering at $15 per share.

Tandem Diabetes Care is set to begin trading on the NASDAQ stock exchange today after pricing its initial public offering of 8 million shares at $15 each, the upper end of its initial range.

The amount the company actually raised could be higher than the $120 million pricing due to a 1.2 million-share over-allotment for the offering's underwriters, which if exercised would push the raise to $138 million. Shares are expected to begin trading today under the TNDM symbol.